The CYP2E1, implicated in liver management of oxidative stress and steatosis, was significantly downregulated by luteolin, indicating that this flavonoid could be behind the antioxidant and antisteatotic effects of the AE (Figure 13G). The gene discussed is CYP2E1; the disease is steatosis.